Emil D. Kakkis

Insider Reports History

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, California
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Emil D. Kakkis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. President & CEO, Director Common Stock 2.24M $113M $50.17 Aug 6, 2024 See FN
Ultragenyx Pharmaceutical Inc. President & CEO, Director Common Stock 565K $28.3M $50.17 Aug 6, 2024 Direct
Ultragenyx Pharmaceutical Inc. President & CEO, Director Stock Option (Right to Buy) 70.1K Mar 1, 2024 Direct

Insider Reports Filed by Emil D. Kakkis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RARE Ultragenyx Pharmaceutical Inc. Aug 6, 2024 1 -$1M 4 Aug 7, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2024 4 -$935K 4 Mar 5, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Feb 7, 2024 1 -$1.35M 4 Feb 8, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Dec 29, 2023 1 -$1.44M 4 Jan 2, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Oct 19, 2023 3 -$1.28M 4 Oct 23, 2023 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2023 4 -$737K 4 Mar 3, 2023 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Dec 30, 2022 1 -$892K 4 Jan 3, 2023 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2022 3 -$819K 4 Mar 3, 2022 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Dec 31, 2021 1 $0 5 Feb 1, 2022 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Oct 14, 2021 1 -$69.1K 4 Oct 18, 2021 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. May 6, 2021 1 -$98.6K 4 May 10, 2021 President & CEO, Director